|
1
|
Moertel CG: Chemotherapy for colorectal
cancer. N Engl J Med. 330:1136–1142. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Joseph NE, Sigurdson ER, Hanlon AL, et al:
Accuracy of determining nodal negativity in colorectal cancer on
the basis of the number of nodes retrieved on resection. Ann Surg
Oncol. 10:213–218. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Baxter NN, Virnig DJ, Rothenberger DA,
Morris AM, Jessurun J and Virnig BA: Lymph node evaluation in
colorectal cancer patients: a population-based study. J Natl Cancer
Inst. 97:219–225. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chang GJ, Rodriguez-Bigas MA, Skibber JM
and Moyer VA: Lymph node evaluation and survival after curative
resection of colon cancer: systematic review. J Natl Cancer Inst.
99:433–441. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mamounas E, Wieand S, Wolmark N, et al:
Comparative efficacy of adjuvant chemotherapy in patients with
Dukes’ B versus Dukes’ C colon cancer: results from four National
Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01,
C-02, C-03, and C-04). J Clin Oncol. 17:1349–1355. 1999.
|
|
6
|
Ratto C, Sofo L, Ippoliti M, et al:
Accurate lymph-node detection in colorectal specimens resected for
cancer is of prognostic significance. Dis Colon Rectum. 42:143–158.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Caplin S, Cerottini JP, Bosman FT,
Constanda MT and Givel JC: For patients with Dukes’ B (TNM stage
II) colorectal carcinoma, examination of six or fewer lymph nodes
is related to poor prognosis. Cancer. 83:666–672. 1998.
|
|
8
|
Nelson H, Petrelli N, Carlin A, et al:
Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer
Inst. 93:583–596. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Prandi M, Lionetto R, Bini A, et al:
Prognostic evaluation of stage B colon cancer patients is improved
by an adequate lymphadenectomy: results of a secondary analysis of
a large scale adjuvant trial. Ann Surg. 235:458–463. 2002.
View Article : Google Scholar
|
|
10
|
Wong SL, Ji H, Hollenbeck BK, Morris AM,
Baser O and Birkmeyer JD: Hospital lymph node examination rates and
survival after resection for colon cancer. JAMA. 298:2149–2154.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Noura S, Ohue M, Kano S, et al: Impact of
metastatic lymph node ratio in node-positive colorectal cancer.
World J Gastrointest Surg. 2:70–77. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nakazaki H: Preoperative and postoperative
cytokines in patients with cancer. Cancer. 70:709–713. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nozoe T, Matsumata T, Kitamura M and
Sugimachi K: Significance of preoperative elevation in serum
C-reactive protein as an indicator for prognosis in colorectal
cancer. Am J Surg. 176:335–338. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nozoe T, Matsumata T and Sugimachi K:
Preoperative elevation of serum C-reactive protein is related to
impaired immunity in patients with colorectal cancer. Am J Clin
Oncol. 23:263–266. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gunter MJ, Stolzenberg-Solomon R, Cross
AJ, et al: A prospective study of serum C-reactive protein and
colorectal cancer risk in men. Cancer Res. 66:2483–2487. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Miki C, Konishi N, Ojima E, Hatada T,
Inoue Y and Kusunoki M: C-reactive protein as a prognostic variable
that reflects uncontrolled up-regulation of the IL-1-IL-6 network
system in colorectal carcinoma. Dig Dis Sci. 49:970–976. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Koike Y, Miki C, Okugawa Y, et al:
Preoperative C-reactive protein as a prognostic and therapeutic
marker for colorectal cancer. J Surg Oncol. 98:540–544. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wiggers T, Arends JW, Schutte B, Volovics
L and Bosman FT: A multivariate analysis of pathologic prognostic
indicators in large bowel cancer. Cancer. 61:386–395. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fletcher RH: Carcinoembryonic antigen. Ann
Int Med. 104:66–73. 1986. View Article : Google Scholar
|
|
20
|
Moertel CG, Fleming TR, Macdonald JS,
Haller DG, Laurie JA and Tangen C: An evaluation of the
carcinoembryonic antigen (CEA) test for monitoring patients with
resected colon cancer. JAMA. 270:943–947. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tepper JE, O’Connell MJ, Niedzwiecki D, et
al: Impact of number of nodes retrieved on outcome in patients with
rectal cancer. J Clin Oncol. 19:157–163. 2001.PubMed/NCBI
|
|
22
|
Joseph NE, Sigurdson ER, Hanlon AL, et al:
Colon cancer survival is associated with increasing number of lymph
nodes analyzed: A secondary survey of intergroup trial INT-0089. J
Clin Oncol. 21:2912–2919. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Swanson RS, Compton CC, Stewart AK and
Bland KI: The prognosis of T3N0 colon cancer is dependent on the
number of lymph nodes examined. Ann Surg Oncol. 10:65–71. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bilimoria KY, Palis B, Stewart AK, et al:
Impact of tumor location on nodal evaluation for colon cancer. Dis
Colon Rectum. 51:154–161. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Leibl S, Tsybrovskyy O and Denk H: How
many lymph nodes are necessary to stage early and advanced
adenocarcinoma of the sigmoid colon and upper rectum? Virchows
Arch. 443:133–138. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Horzic M and Kopljar M: Minimal number of
lymph nodes that need to be examined for adequate staging of
colorectal cancer – factors influencing lymph node harvest.
Hepatogastroenterology. 52:86–89. 2005.PubMed/NCBI
|
|
27
|
AJCC Cancer Staging Manual. 6th edition.
Springer; New York: 2002
|
|
28
|
Le Voyer TE, Sigurdson ER, Hanlon AL, et
al: Colon cancer survival is associated with increasing number of
lymph nodes analyzed: a secondary survey of intergroup trial
INT-0089. J Clin Oncol. 21:2912–2919. 2003.PubMed/NCBI
|
|
29
|
Nitti D, Marchet A, Olivieri M, et al:
Ratio between metastatic and examined lymph nodes is an independent
prognostic factor after D2 resection for gastric cancer: analysis
of a large European monoinstitutional experience. Ann Surg Oncol.
10:1077–1085. 2003. View Article : Google Scholar
|
|
30
|
Voordeckers M, Vinh-Hung V, Van de Steene
J, Lamote J and Storme G: The lymph node ratio as prognostic factor
in node-positive breast cancer. Radiother Oncol. 70:225–230. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Berger AC, Watson JC, Ross EA and Hoffman
JP: The metastatic/examined lymph node ratio is an important
prognostic factor after pancreaticoduodenectomy for pancreatic
adenocarcinoma. Am Surg. 70:235–240. 2004.
|
|
32
|
Inoue K, Nakane Y, Iiyama H, et al: The
superiority of ratio-based lymph node staging in gastric carcinoma.
Ann Surg Oncol. 9:27–34. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Berger AC, Sigurdson ER, LeVoyer T, et al:
Colon cancer survival is associated with decreasing ratio of
metastatic to examined lymph nodes. J Clin Oncol. 23:8706–8712.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lee HY, Choi HJ, Park KJ, et al:
Prognostic significance of metastatic lymph node ratio in
node-positive colon carcinoma. Ann Surg Oncol. 14:1712–1717. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang J, Hassett JM, Dayton MT and Kulaylat
MN: Lymph node ratio: role in the staging of node-positive colon
cancer. Ann Surg Oncol. 15:1600–1608. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rosenberg R, Friederichs J, Schuster T, et
al: Prognosis of patients with colorectal cancer is associated with
lymph node ratio: a single-center analysis of 3,026 patients over a
25-year time period. Ann Surg. 248:968–978. 2008.PubMed/NCBI
|
|
37
|
Peng J, Xu Y, Guan Z, et al: Prognostic
significance of the metastatic lymph node ratio in node-positive
rectal cancer. Ann Surg Oncol. 15:3118–3123. 2008. View Article : Google Scholar : PubMed/NCBI
|
